Literature DB >> 20055720

Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings.

Melek Karademir1, Ismail Hakan Koseoglu, Kevser Vatansever, Marjan Van Den Akker.   

Abstract

OBJECTIVES: To assess the validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary care in Turkey.
METHODS: To develop a Turkish version of the scale, it was translated into Turkish then back-translated into English. The final version was used in a survey in two urban primary health care centers in Izmir, Turkey. For assessing the validity of Turkish scale, we performed factor analysis to test construct validity. Reliability was assessed by calculating the Cronbach's alpha as a measure of internal consistency.
RESULTS: Factor analysis revealed a three-factor structure representing unintentional medication non-adherence; intentional medication non-adherence; and salt intake adherence. Percentages of explained variance were 33.3%, 14.6% and 11.2% respectively. When forcing a two-factor structure we found salt intake and medication adherence clusters. Cronbach's alpha was 0.72 and 0.83 for medication adherence and whole scale, respectively.
CONCLUSION: The Turkish Hill-Bone scale presented a factor structure consistent with the original scale, had a high level of internal consistency. It can be used for assessing hypertension patients' compliance in Turkish primary care settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20055720     DOI: 10.3109/13814780903452150

Source DB:  PubMed          Journal:  Eur J Gen Pract        ISSN: 1381-4788            Impact factor:   1.904


  7 in total

1.  Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review.

Authors:  Henok G Tegegn; Stuart Wark; Edouard Tursan d'Espaignet; M Joy Spark
Journal:  Clin Drug Investig       Date:  2022-10-01       Impact factor: 3.580

2.  The Translation, Reliability and Validity of the Chinese Version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in Adults with Hypertension.

Authors:  Jingjing Pan; Bin Hu; Lian Wu; Huichuan Wang; Tao Lei; Zhiyu Liu
Journal:  Patient Prefer Adherence       Date:  2020-10-09       Impact factor: 2.711

3.  Validity and reliability of the Malay version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary healthcare settings in Malaysia: A cross-sectional study.

Authors:  A T Cheong; S F Tong; S G Sazlina
Journal:  Malays Fam Physician       Date:  2015-08-31

4.  Family support and medication adherence among residents with hypertension in informal settlements of Nairobi, Kenya: a mixed-method study.

Authors:  Shangzhi Xiong; Nicholas Peoples; Truls Østbye; Michael Olsen; Xuefeng Zhong; Caroline Wainaina; Shujun Fan; David Wambui; Lijing L Yan
Journal:  J Hum Hypertens       Date:  2022-01-19       Impact factor: 3.012

5.  Psychometric evaluation of the Polish adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale.

Authors:  Izabella Uchmanowicz; Beata Jankowska-Polańska; Anna Chudiak; Anna Szymańska-Chabowska; Grzegorz Mazur
Journal:  BMC Cardiovasc Disord       Date:  2016-05-10       Impact factor: 2.298

6.  Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications.

Authors:  M M Nashilongo; B Singu; F Kalemeera; M Mubita; E Naikaku; A Baker; A Ferrario; B Godman; L Achieng; D Kibuule
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

7.  Translation, Cultural Adaptation and Validation of the Hill Bone Compliance to High Blood Pressure Therapy Scale to Nepalese Language.

Authors:  Rajina Shakya; Rajeev Shrestha; Sunil Shrestha; Priti Sapkota; Roshani Gautam; Lalita Rai; Asmita Priyadarshini Khatiwada; Kamal Ranabhat; Bhuvan Kc; Binaya Sapkota; Saval Khanal; Vibhu Paudyal
Journal:  Patient Prefer Adherence       Date:  2022-04-08       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.